Point72 Asset Management

Point72 Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Point72 Asset Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$2.16M	Buy
2019 Q2	$1.02M	Buy
2014 Q3	–	Sell
2014 Q2	$3.06M	Buy